SCHEMBL474916

SCHEMBL474916

CCC(=O)[N]C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL389016 0.83
SCHEMBL98446 0.75
SCHEMBL9560717 0.73 CES1 (0.48)
SCHEMBL6975600 0.71 ALDH1A1 (0.43)
SCHEMBL7059217 0.69 TDP1 (0.32)
SCHEMBL879224 0.67
SCHEMBL42538 0.67
SCHEMBL2517088 0.67
SCHEMBL1509717 0.67
SCHEMBL734443 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1174151-B1 THERAPEUTIC TREATMENT OF EOSINOPHILIA USING CHYMASE INHIBITORS AS THE ACTIVE INGREDIENT DAIICHI ASUBIO PHARMA CO LTD (JP) 2007-01-24 EP claimed
US-6677344-B2 Chymase inhibitor for the treatment of eosinophilia DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2004-01-13 US claimed
US-6500835-B2 FOR PROPHYLAXIS AND THERAPY OF FIBROSIS INVOLVING EXTRACELLULAR MATRIX DYSBOLISM HAVING A CHYMASE INHIBITOR AS AN EFFECTIVE INGREDIENT; SIDE EFFECT REDUCTION SUNTORY LIMITED (JP) 2002-12-31 US claimed
US-5393760-A Cardiovascular disorders, antitumor agents HOFFMANN-LA ROCHE INC. (US) 1995-02-28 US claimed
EP-0468231-B1 Guanidins HOFFMANN LA ROCHE (CH) 1994-09-21 EP claimed
EP-0468231-A2 Guanidins F. HOFFMANN-LA ROCHE AG (CH) 1992-01-29 EP claimed
EP-0107850-B1 AMINOGLYCOSIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-04-06 EP claimed
US-4493831-A ANTIBIOTICS, VIRICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-01-15 US claimed
EP-0107850-A1 Aminoglycoside derivatives, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-05-09 EP claimed
US-20230146909-A1 DYE INK COMPOSITION, BLACK DYE INK, INK JET RECORDING DYE INK, INK JET RECORDING METHOD, AND AQUEOUS DYE SOLUTION FUJIFILM CORPORATION (JP) 2023-05-11 US disclosed
US-9107953-B2 Sustained release composition containing SDF-1 ONO PHARMACEUTICAL CO., LTD. (JP) 2015-08-18 US disclosed
US-20130243824-A1 SUSTAINED RELEASE COMPOSITION CONTAINING SDF-1 ONO PHARMACEUTICAL CO., LTD. (JP) 2013-09-19 US disclosed
US-8435953-B2 Sustained release composition containing SDF-1 Tabata, Yasuhiko (JP) 2013-05-07 US disclosed
EP-2218459-B1 SUSTAINED RELEASE COMPOSITION CONTAINING SDF-1 ONO PHARMACEUTICAL CO (JP) 2012-02-01 EP disclosed
EP-0468231-A2 Guanidins F. HOFFMANN-LA ROCHE AG (CH) 1992-01-29 EP disclosed
EP-0466125-A2 Styryl compounds and their pharmaceutical use YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1992-01-15 EP disclosed
US-5053494-A FIBER REACTIVE POLYAZO DYE HAVING TWO VINYLSULFONE TYPE REACTIVE GROUPS THROUGH TRIAZINYL BRIDGING GROUP SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-10-01 US disclosed
EP-0266774-B1 POLYAZO COMPOUND HAVING TWO VINYLSULFONE TYPE FIBER REACTIVE GROUPS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-08-28 EP disclosed
EP-0316013-A2 Silver halide photographic material having at least one dyed hydrophilic colloid layer Fuji Photo Film Co., Ltd. (JP) 1989-05-17 EP disclosed
EP-0266774-A1 Polyazo compound having two vinylsulfone type fiber reactive groups SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-05-11 EP disclosed